Przy przeliczeniach molowych uwzgldnij mas czsteczki ~4813,5 g/mol
The broader peptide therapy guide covers the general principles of working with therapeutic peptides
This is purely a tolerance measure, not a clinical requirement
Semaglutide, however, has the most mature evidence for cardiovascular risk reduction, as demonstrated in the SUSTAIN-6, PIONEER-6, and SELECT trials
In 2024, Novo generated roughly half its revenue from GLP-1s, while Ely Lilly earned $10.4 billion of its $15.6 billion total revenue from key products, illustrating that despite its broad pipeline, Eli Lilly is becoming more concentrated in its commercial performance of these key drugs
That point matters